EGFR and non-small cell lung carcinoma: We provide a comprehensive analysis of recent artificial intelligence–based approaches for predicting epidermal growth factor receptor (EGFR) mutation status in non-small cell lung cancer (NSCLC), detailing the research methods, data modalities, and model performance (39, 40).